Amiodarone Hci 51662-1363-01
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 8, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA075761
Need to source Amiodarone Hci? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amiodarone Hydrochloride | 50 mg/mL |
Drug Class
Antiarrhythmic [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]
Selected Package
51662-1363-01Selected3 mL in 1 VIAL, SINGLE-DOSE (51662-1363-1)